Mitral Valve Prolapse Class IIa

1. To exclude MVP in patients who have been diagnosed but without clinical evidence to support the diagnosis
2. To exclude MVP in patients with first-degree relatives with known myxomatous valve disease
3. Risk stratification in patients with physical signs or known MVP